Kiyeon assists biopharma companies of all stages: from having just an innovative idea, to building sales network around the world. Depending on the stage of the product in development, we assist with various stage-specific tasks: securing IP, taking the product through clinical trials and obtain approvals, monetizing IP assets through various transactions e.g., licensing, partnering, spin offs, and sale of companies.
Intellectual Property
We strive to help clients identify, protect and leverage the value of their intellectual assets. Before we became lawyers, we were scientists with years of experience in our respective fields. With our strong technical backgrounds, we are able to truly understand our clients’ technologies, asses their potential in view of the patent landscape, and bring forth a strategy that would maximize the value of the patent portfolios, defend the client’s market position, and preempt potential challenges and pitfalls brought by the competitors and ever-changing market conditions. Our IP services include:
Patent Prosecution
Infringement, Non-infringement, and Patentability Legal Opinion
Freedom to Operate Analysis
IP Due Diligence
Trademarks and Copyrights
Biotech Transactions
Technology-driven companies face the unique challenge of maximizing the value of their IP assets. We draw from their years of experience in corporate transactions, and help clients choose the best instrument or vehicle to successfully monetize their IP assets. Our corporate transactional services include:
Acquisition
Licensing
Technology Transfer
Joint Venture Structuring
Clinical Development
Clinical development is at the core of strengthening market competitiveness for a biopharma company. Successful clinical development requires the execution of a series of tasks, each building on the success of another task. Like a general contractor of a construction project, we fetch resources necessary for a particular stage of the development, deploy the resource according to well-choreographed plan, and ensure the execution is within the budget. Clinical development is full of surprises and pitfalls. Our strength in managing the clinical development as a command and control center lies in our ability to draw from our experiences. Working with us, our clients avoid rookie mistakes, enjoy speedy development, and head off any issues long before they become a liability. We manage all aspects of:
cGMP compliance
FDA submissions (IND, PMA, 510(k), De novo, Orphan, HUD, or RMAT)